A-R-T- Advisors Boosted Its Holding in Bristol Myers Squibb Co (BMY) by $9.39 Million as Shares Declined; As Paychex (PAYX) Shares Declined, Ensemble Capital Management Has Increased Its Stake by $3.85 Million

February 20, 2018 - By reb123z

A-R-T- Advisors Llc increased its stake in Bristol Myers Squibb Co (BMY) by 365.53% based on its latest 2017Q3 regulatory filing with the SEC. A-R-T- Advisors Llc bought 149,100 shares as the company’s stock declined 1.04% while stock markets rallied. The hedge fund held 189,890 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $12.10M, up from 40,790 at the end of the previous reported quarter. A-R-T- Advisors Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $110.66 billion market cap company. The stock decreased 1.71% or $1.18 during the last trading session, reaching $67.78. About 4.94 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 20, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Ensemble Capital Management Llc increased its stake in Paychex Inc (PAYX) by 12.3% based on its latest 2017Q3 regulatory filing with the SEC. Ensemble Capital Management Llc bought 65,215 shares as the company’s stock declined 2.74% while stock markets rallied. The institutional investor held 595,325 shares of the consumer services company at the end of 2017Q3, valued at $35.70M, up from 530,110 at the end of the previous reported quarter. Ensemble Capital Management Llc who had been investing in Paychex Inc for a number of months, seems to be bullish on the $23.53 billion market cap company. The stock decreased 1.95% or $1.3 during the last trading session, reaching $65.51. About 1.08 million shares traded. Paychex, Inc. (NASDAQ:PAYX) has risen 11.22% since February 20, 2017 and is uptrending. It has underperformed by 5.48% the S&P500.

Since September 6, 2017, it had 1 insider purchase, and 2 insider sales for $646,385 activity. $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr. on Tuesday, December 12. Samuels Theodore R. II bought $249,187 worth of stock.

A-R-T- Advisors Llc, which manages about $4.41B and $1.96 billion US Long portfolio, decreased its stake in Cdn Imperial Bk Comm Toronto (NYSE:CM) by 8,300 shares to 3,183 shares, valued at $278,000 in 2017Q3, according to the filing. It also reduced its holding in Coca Cola European Partners by 20,326 shares in the quarter, leaving it with 9,974 shares, and cut its stake in Caterpillar Inc Del (NYSE:CAT).

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 9 Hold. Therefore 37% are positive. Bristol-Myers Squibb Company had 73 analyst reports since July 28, 2015 according to SRatingsIntel. Piper Jaffray maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Thursday, October 26. Piper Jaffray has “Hold” rating and $60.0 target. Cowen & Co maintained it with “Hold” rating and $65.0 target in Thursday, October 19 report. The rating was upgraded by SunTrust to “Buy” on Monday, October 30. The firm has “Neutral” rating given on Friday, October 27 by Credit Suisse. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Sell” rating given on Monday, June 5 by BMO Capital Markets. On Sunday, July 23 the stock rating was maintained by BMO Capital Markets with “Sell”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Monday, October 16. Jefferies upgraded Bristol-Myers Squibb Company (NYSE:BMY) on Monday, December 19 to “Buy” rating. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Piper Jaffray on Thursday, July 27. The firm has “Sell” rating by Societe Generale given on Wednesday, April 6.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Shelton Capital invested in 32,445 shares or 0.16% of the stock. Perritt has invested 0.1% in Bristol-Myers Squibb Company (NYSE:BMY). Altavista Wealth Management Inc has invested 0.28% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Acropolis Invest Management Ltd Llc reported 2,047 shares. Welch Forbes Limited Liability owns 0.39% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 234,101 shares. Ghp Advsr reported 0.05% in Bristol-Myers Squibb Company (NYSE:BMY). Fairfield Bush & holds 17,796 shares or 0.35% of its portfolio. Private Commerce Na has 63,988 shares. Private Wealth Prtnrs Lc stated it has 6,820 shares. Grandfield & Dodd Limited Liability Company stated it has 16,309 shares or 0.12% of all its holdings. Investors Asset Of Georgia Ga Adv invested in 6,688 shares. Bradley Foster & Sargent Incorporated Ct stated it has 47,868 shares or 0.12% of all its holdings. Boston Family Office Ltd Limited Liability Company holds 0.3% or 40,854 shares in its portfolio. British Columbia Investment Mngmt accumulated 948,710 shares or 0.47% of the stock. Grassi Investment Management holds 0.88% or 81,706 shares in its portfolio.

Ensemble Capital Management Llc, which manages about $381.11 million and $477.10 million US Long portfolio, decreased its stake in Pepsico Inc (NYSE:PEP) by 91,055 shares to 19,180 shares, valued at $2.14 million in 2017Q3, according to the filing. It also reduced its holding in Advisory Brd Co (NASDAQ:ABCO) by 324,940 shares in the quarter, leaving it with 35,750 shares, and cut its stake in Alphabet Inc.

Investors sentiment decreased to 1.02 in 2017 Q3. Its down 0.01, from 1.03 in 2017Q2. It dived, as 57 investors sold PAYX shares while 263 reduced holdings. 65 funds opened positions while 260 raised stakes. 238.82 million shares or 0.48% more from 237.67 million shares in 2017Q2 were reported. 9,220 are owned by Choate Investment Advisors. Daiwa Secs Group owns 9,847 shares for 0% of their portfolio. Opus Mgmt reported 99,700 shares. Duncker Streett & Comm Incorporated has invested 0.12% in Paychex, Inc. (NASDAQ:PAYX). Stadion Money Management Ltd Liability Corp invested in 0.02% or 8,923 shares. Regions Finance holds 0.09% of its portfolio in Paychex, Inc. (NASDAQ:PAYX) for 129,275 shares. Bb&T invested in 19,686 shares. Dimensional Fund Advisors Lp reported 0.03% of its portfolio in Paychex, Inc. (NASDAQ:PAYX). Enterprise Svcs holds 0.02% in Paychex, Inc. (NASDAQ:PAYX) or 621 shares. Fairfield Bush Company holds 0.18% of its portfolio in Paychex, Inc. (NASDAQ:PAYX) for 9,600 shares. Investment Mgmt Of Virginia Llc holds 0.05% of its portfolio in Paychex, Inc. (NASDAQ:PAYX) for 3,900 shares. Bokf Na invested in 0.08% or 46,557 shares. The Illinois-based Segall Bryant Hamill Ltd Limited Liability Company has invested 0.01% in Paychex, Inc. (NASDAQ:PAYX). Ftb Advisors has 5,478 shares. 17,365 are owned by State Of Alaska Department Of Revenue.

Among 18 analysts covering Paychex (NASDAQ:PAYX), 1 have Buy rating, 2 Sell and 15 Hold. Therefore 6% are positive. Paychex had 44 analyst reports since August 14, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Hold” rating in Thursday, August 17 report. On Friday, August 18 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Hold” rating given on Friday, September 4 by Zacks. The company was maintained on Wednesday, October 4 by Bank of America. The rating was maintained by Argus Research on Thursday, December 24 with “Buy”. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, December 20. The stock has “Mkt Perform” rating by Bernstein on Wednesday, January 11. The firm has “Sell” rating given on Thursday, December 21 by RBC Capital Markets. The company was maintained on Monday, September 11 by Robert W. Baird. The stock of Paychex, Inc. (NASDAQ:PAYX) has “Neutral” rating given on Friday, August 14 by JP Morgan.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>